Literature DB >> 11884237

Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications.

Gary B Quistad1, Susan E Sparks, Yoffi Segall, Daniel K Nomura, John E Casida.   

Abstract

Fatty acid amide hydrolase (FAAH) plays an important role in nerve function by regulating the action of endocannabinoids (e.g., anandamide) and hydrolyzing a sleep-inducing factor (oleamide). Several organophosphorus pesticides and related compounds are shown in this study to be more potent in vivo inhibitors of mouse brain FAAH than neuropathy target esterase (NTE), raising the question of the potential toxicological relevance of FAAH inhibition. These FAAH-selective compounds include tribufos and (R)-octylbenzodioxaphosphorin oxide with delayed neurotoxic effects in mice and hens plus several organophosphorus pesticides (e.g., fenthion) implicated as delayed neurotoxicants in humans. The search for a highly potent and selective inhibitor for FAAH relative to NTE for use as a toxicological probe culminated in the discovery that octylsulfonyl fluoride inhibits FAAH by 50% at 2 nM in vitro and 0.2 mg/kg in vivo and NTE is at least 100-fold less sensitive in each case. More generally, the studies revealed 12 selective in vitro inhibitors for FAAH (mostly octylsulfonyl and octylphosphonyl derivatives) and 9 for NTE (mostly benzodioxaphosphorin oxides and organophosphorus fluoridates). The overall in vivo findings with 16 compounds indicate the expected association of AChE inhibition with acute or cholinergic syndrome and >70% brain NTE inhibition with delayed neurotoxic action. Surprisingly, 75-99% brain FAAH inhibition does not lead to any overt neurotoxicity or change in behavior (other than potentiation of exogenous anandamide action). Thus, FAAH inhibition in mouse brain does not appear to be a primary target for organophosphorus pesticide-induced neurotoxic action (cholinergic or intermediate syndrome or delayed neurotoxicity).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884237     DOI: 10.1006/taap.2001.9342

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  19 in total

1.  Comparative effects of chlorpyrifos in wild type and cannabinoid Cb1 receptor knockout mice.

Authors:  Praveena Baireddy; Jing Liu; Myron Hinsdale; Carey Pope
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-13       Impact factor: 4.219

2.  Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following Developmental Chlorpyrifos Exposure in Rats.

Authors:  Robert W Buntyn; Navatha Alugubelly; Rachel L Hybart; Afzaal N Mohammed; Carole A Nail; Greta C Parker; Matthew K Ross; Russell L Carr
Journal:  Int J Toxicol       Date:  2017-08-18       Impact factor: 2.032

3.  Inhibition of fatty acid amide hydrolase by chlorpyrifos in juvenile rats results in altered exploratory and social behavior as adolescents.

Authors:  Russell L Carr; Navatha Alugubelly; Kathryne de Leon; Louise Loyant; Afzaal N Mohammed; M Elizabeth Patterson; Matthew K Ross; Nicole E Rowbotham
Journal:  Neurotoxicology       Date:  2020-01-10       Impact factor: 4.294

Review 4.  Organophosphorus Compounds at 80: Some Old and New Issues.

Authors:  Lucio G Costa
Journal:  Toxicol Sci       Date:  2018-03-01       Impact factor: 4.849

5.  Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.

Authors:  Galina F Makhaeva; Elena V Rudakova; Nichole D Hein; Olga G Serebryakova; Nadezhda V Kovaleva; Natalia P Boltneva; John K Fink; Rudy J Richardson
Journal:  J Appl Toxicol       Date:  2014-01-07       Impact factor: 3.446

6.  The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.

Authors:  Jing Liu; Carey Pope
Journal:  Neurotoxicology       Date:  2014-11-20       Impact factor: 4.294

7.  Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors.

Authors:  Sandra Holt; Francesca Comelli; Barbara Costa; Christopher J Fowler
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

8.  Endocannabinoid signaling in neurotoxicity and neuroprotection.

Authors:  C Pope; R Mechoulam; L Parsons
Journal:  Neurotoxicology       Date:  2009-12-05       Impact factor: 4.294

Review 9.  The pharmacology of the cannabinoid system--a question of efficacy and selectivity.

Authors:  Christopher J Fowler
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

10.  Induction of endocannabinoid levels in juvenile rat brain following developmental chlorpyrifos exposure.

Authors:  Russell L Carr; Ashley L Adams; Darin R Kepler; Antonio B Ward; Matthew K Ross
Journal:  Toxicol Sci       Date:  2013-06-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.